SCHEMBL4786228

SCHEMBL4786228

Cc1nc(-c2cc(Cl)cc(Cl)c2)[nH]c1C(=O)NC(=N)N

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 7/20 0.46
PIN1 Q13526 3/20 0.34
PARP1 P09874 1/20 0.33
JUN P05412 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
ASIC3 Q9UHC3 1/20 0.32
CHEK2 O96017 2/20 0.31
ALDH1A1 P00352 1/20 0.31
GFER P55789 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
MAPK1 P28482 1/20 0.31
MAP2 P11137 1/20 0.30
CNR1 P21554 1/20 0.30
CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4788030 0.83 SLC9A1 (0.40) SLC9A1PARP1CHEK2MAPK1
SCHEMBL4787686 0.82 SLC9A1 (0.51) SLC9A1PIN1CHEK2
SCHEMBL4785742 0.81 SLC9A1 (0.53) SLC9A1PIN1
SCHEMBL4785802 0.78 SLC9A1 (0.40) SLC9A1PIN1CHEK2ALDH1A1
SCHEMBL4787499 0.77 SLC9A1 (0.56) SLC9A1ALDH1A1RXFP1
SCHEMBL4787790 0.76 SLC9A1 (0.54) SLC9A1PIN1
SCHEMBL4786233 0.76 SLC9A1 (0.68) SLC9A1
SCHEMBL4788116 0.76 SLC9A1 (0.40) SLC9A1CHEK2ALDH1A1
SCHEMBL4787952 0.75 SLC9A1 (0.56) SLC9A1PIN1
SCHEMBL4787537 0.74 SLC9A1 (0.54) SLC9A1PARP1ALDH1A1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008111794-A1 4-METHYLIMIDAZOL-5-YLCARBONYLGUANIDINE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE ISCHEMIC HEART DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA RESERACH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-09-18 WO disclosed